Capital World Investors Organon & Co. Transaction History

Capital World Investors

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$23.31 - $28.61 $112,237 - $137,757	4,815 Added 1.35%	360,217 $10.1 Million
Q3 2022 Nov 14, 2022	SELL	$23.4 - $34.25 $138,153 - $202,212	-5,904 Reduced 1.63%	355,402 $8.32 Million
Q2 2022 Aug 15, 2022	BUY	$31.66 - $38.9 $325,686 - $400,164	10,287 Added 2.93%	361,306 $12.2 Million
Q1 2022 May 19, 2022	BUY	$30.45 - $39.36 $10.7 Million - $13.8 Million	351,019 New	351,019 $12.3 Million
Q1 2022 May 16, 2022	SELL	$30.45 - $39.36 $15.2 Million - $19.6 Million	-498,198 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$28.67 - $37.13 $248,568 - $321,917	8,670 Added 1.77%	498,198 $15.2 Million
Q3 2021 Nov 15, 2021	BUY	$28.63 - $35.64 $2,920 - $3,635	102 Added 0.02%	489,528 $16.1 Million
Q2 2021 Aug 16, 2021	BUY	$28.45 - $38.0 $13.9 Million - $18.6 Million	489,426 New	489,426 $14.8 Million

794

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $4.11B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Capital World Investors, based on Form 13F filings with the SEC.

Stay updated on Capital World Investors with notifications on news.